LKFT · Lakefront Biotherapeutics NV · Analyst Estimates
$32.28
-0.05 (-0.15%)
At close · Oct 30
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$2.13B
Shares
65.90M
Volume · Oct 30
164.06K
Avg daily vol (3M)
283.93K
Analyst Estimates
Compare analyst forecasts for Lakefront Biotherapeutics NV across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-20 17:04 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
-0.71
|
-0.71
|
-0.71
|
1
|
-0.71
|
-0.71
|
-0.71
|
-13.24
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
18.59M
|
117.22M
|
299.33M
|
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
-1.75
|
-1.06
|
-0.37
|
2
|
-1.06
|
-1.06
|
-1.06
|
-1.72
|
0
|
0
|
0
|
0
|
|
Revenue
EUR
Publication date not stated |
27.82M
|
84.62M
|
212.78M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
0.23
|
0.23
|
0.23
|
1
|
0.23
|
0.23
|
-0.49
|
-1.31
|
0
|
0
|
0
|
0
|
|
Revenue
EUR
Publication date not stated |
7.52M
|
41.18M
|
74.83M
|
2
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
EUR
Publication date not stated |
-0.54
|
-0.17
|
0.21
|
2
|
-0.17
|
-0.17
|
-0.17
|
-0.72
|
0
|
0
|
0
|
0
|
|
Revenue
EUR
Publication date not stated |
7.65M
|
106.78M
|
205.91M
|
2
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
14 filings
14 filers
Visit website
Investor relations